Systematic review / meta-analysis / 2024
Red yeast rice extract consumption significantly reduced total cholesterol and LDL-C in clinical trials without threatening side effects.
A systematic review and meta-analysis evaluated 14 double-blind clinical trials lasting 4 to 24 weeks on red yeast rice (RYR) extract consumption and lipid profile parameters. RYR extract significantly reduced total cholesterol (mean absolute reduction: 37.43 mg/dL; 95% CI: -47.08, -27.79) and LDL-C (mean absolute reduction: 35.82 mg/dL; 95% CI: -43.36, -28.29). It did not significantly alter HDL-C, triglycerides, or apolipoproteins A-I and B. RYR extract was considered safe, with neither threatening nor frequent side effects observed.
- Study type
- Systematic review and meta-analysis of clinical trials
- Who was studied
- People with hypercholesterolemia in 14 double-blind clinical trials
- What was measured
- Lipid profile parameters (total cholesterol, LDL-C, HDL-C, triglycerides, apolipoproteins A-I and B) and safety/side effects
THE PAPER
Safety and Efficacy of the Consumption of the Nutraceutical "Red Yeast Rice Extract" for the Reduction of Hypercholesterolemia in Humans: A Systematic Review and Meta-Analysis.
Trogkanis E, Karalexi MA, Sergentanis TN, Kornarou E, Vassilakou T. Nutrients, 2024.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.